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Abstract The growing use of interventional and fluoro-
scopic imaging in children represents a tremendous benefit
for the diagnosis and treatment of benign conditions. Along
with the increasing use and complexity of these procedures
comes concern about the cancer risk associated with
ionizing radiation exposure to children. Children are
considerably more sensitive to the carcinogenic effects of
ionizing radiation than adults, and children have a longer
life expectancy in which to express risk. Numerous
epidemiologic cohort studies of childhood exposure to
radiation for treatment of benign diseases have demonstra-
ted radiation-related risks of cancer of the thyroid, breast,
brain and skin, as well as leukemia. Many fewer studies
have evaluated cancer risk following diagnostic radiation
exposure in children. Although radiation dose for a single
procedure might be low, pediatric patients often receive
repeated examinations over time to evaluate their condi-
tions, which could result in relatively high cumulative
doses. Several cohort studies of girls and young women
subjected to multiple diagnostic radiation exposures have
been informative about increased mortality from breast
cancer with increasing radiation dose, and case-control
studies of childhood leukemia and postnatal diagnostic
radiation exposure have suggested increased risks with an
increasing number of examinations. Only two long-term
follow-up studies of cancer following cardiac catheteriza-
tion in childhood have been conducted, and neither
reported an overall increased risk of cancer. Most cancers
can be induced by radiation, and a linear dose-response has
been noted for most solid cancers. Risks of radiation-
related cancer are greatest for those exposed early in life,
and these risks appear to persist throughout life.
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Introduction
The growing use of interventional and fluoroscopic
imaging in children represents a tremendous benefit for
the diagnosis and treatment of benign conditions. Along
with the increasing use and complexity of these procedures
comes concern about the late effects of increased ionizing
radiation exposure to children. Although radiation dose for
a single procedure might be low, pediatric patients often
receive repeated examinations over time to evaluate their
conditions, which could result in relatively high cumulative
doses. Most important, children are considerably more
sensitive to the carcinogenic effects of ionizing radiation
than adults, and children have a longer life expectancy
resulting in a larger window of opportunity for expressing
radiation damage. In addition to the studies of Japanese
atomic bomb survivors, which have provided a wealth of
data about radiation-related cancer risks, numerous epide-
miologic studies of childhood exposure to radiation (X-rays
and gamma rays) for treatment of benign diseases have
demonstrated increased cancer risks with increasing radi-
ation dose [1–3]. These studies have been extensively
reviewed recently in the BEIR VII report “Health Risks
from Exposure to Low Levels of Ionizing Radiation” [3],
which concluded that the “available biological and bio-
physical data supports a ‘linear-no-threshold’ (LNT) risk
model – that the risk of cancer proceeds in a linear fashion
at lower doses without a threshold and that the smallest
dose has the potential to cause a small increase in risk to
humans.” This paper highlights the major studies of cancer
risk following childhood irradiation for treatment of benign
disease and postnatal diagnostic radiation exposure.
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Fax: +1-301-4020207Characteristics of epidemiologic studies of radiation
exposure
Many of the classic epidemiologic studies of cancer
following medical radiation exposure are distinguished
by a cohort design, large population size, long-term follow-
up of the cohort, well-characterized dose estimates for
individuals, and a wide range of doses in order to estimate a
dose-response relationship. Studies based on a cohort
design are generally less likely to be biased than case-
control studies that depend on the retrospective collection
of data. Large population size is usually required to
evaluate the risk of cancer, because cancer is a rare
outcome, especially in children. In addition, the lower the
radiation dose, the larger the population size required to
detect a radiation effect [4]. Although radiation-induced
leukemia generally occurs within 3 to 5 years of radiation
exposure, solid tumors usually start to be diagnosed a
minimum of 10 to 15 years after exposure and often do not
appear until the child has reached adulthood [1]. Therefore,
study subjects, especially children, usually need to be
monitored for many years for solid cancer development.
Radiation-related cancer risk is typically expressed as
excess relative risk (ERR) or excess absolute risk (EAR),
which facilitates comparison across studies. Both of these
measures of radiation risk represent increased cancer rates
relative to an unexposed population, on a relative scale
(ERR) or an absolute scale (EAR). For example, an ERR of
1 corresponds to a doubling of the cancer rate in the
exposed population compared to the unexposed popula-
tion, whereas an EAR represents the additional number of
cancers in the exposed population compared to the number
of cancers in the unexposed population.
Severalfactorsmightmodifytheriskofcancerfollowing
radiation exposure. These factors include: gender (e.g.,
females are more sensitive than males to the carcinogenic
effectsofradiationtothethyroid);ageatexposure(younger
children are more susceptible to radiation effects than older
children); attained age (cancer might not appear until the
childhasreachedadulthood,whencancerstypicallyoccur);
time since exposure (solid tumors start to appear 10–
15 years after exposure); underlying disease (disease
requiring radiation treatment might predispose to cancer);
and other potential carcinogens (cigarette smoking might
interact with radiation exposure).
Studies of children irradiated for benign diseases
Studies of pediatric patients irradiated for benign diseases
avoid possible confounding by the presence of existing
malignant disease, and these patients generally receive
lower doses of radiation than children being treated for
cancer. Detailed radiotherapy records usually exist to
permit quantification of the radiation dose received by the
child. Treatments are usually partial-body, and doses might
be fractionated or protracted, depending on the treatment
schedule, and non-irradiated patients are often available for
comparison.
The most radiosensitive organ sites in children in order
of sensitivity are the thyroid gland, breasts, bone marrow
(leukemia), brain and skin [1]. The evidence for increased
radiation-related risk for these cancers following childhood
therapeutic radiation has come from long-term cohort
studies of infants irradiated for suspected enlarged thymus
glands or hemangiomas of the face and neck, and young
children irradiated for tinea capitis of the scalp or for
enlarged tonsils (Table 1).
Table 1 Cancer risks following childhood therapeutic irradiation for benign diseases
Cancer site Benign condition, cohort No. of irradiated subjects Mean age (years) Mean dose (Gy) ERR/Gy (95% CI)
Thyroid Tinea capitis, Israel 10,834 7.1 0.1 32 (14–57)
Tinea capitis, New York 2,224 7.8 0.1 7.7 (<0–60)
Hemangioma
a, Gotenburg 11,914 <1.5 0.1 7.5 (0.4–18)
Hemangioma
a, Stockholm 14,435 <1.5 0.3 4.9 (1.3–10)
Enlarged tonsils, Chicago 2,634 4 0.6 2.5 (0.6–26)
Thymus, Rochester, NY 2,650 <1 1.4 9.1 (3.6–29)
Breast Hemangioma (pooled)
a 17,202 0.5 0.3 0.4 (0.2–0.6)
Thymus, Rochester, NY 1,201 <1 0.7 2.5 (1.1–5.2)
Leukemia Tinea capitis, Israel 10,834 7.1 0.3 Not available
Hemangioma (pooled)
a 28,008 0.5 0.1 1.6 (−0.6–5.5)
Brain Tinea capitis, Israel 10,834 7.1 1.5 4.6 (2.4–9.1)
b
1.5 2.0 (0.7–4.7)
c
Hemangioma (pooled)
a 28,008 0.5 0.1 2.7 (1.0–5.6)
d
Skin Tinea capitis, Israel 10,834 7.1 6.1 0.7 (0.3–1.4)
Tinea capitis, New York 2,224 7.8 4.3 1.6 (1.3–2.1)
aRadium-226 treatment
bBenign tumor only
cMalignant tumor only
dBenign and malignant tumors combined
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Although thyroid cancer is rare, six large cohort studies of
childhood irradiation have demonstrated a radiation-related
risk for thyroid cancer. Children were irradiated for either
tinea capitis of the scalp [5, 6], suspected enlarged thymus
glands [7], enlarged tonsils [8], or a hemangioma on the
face or neck [9, 10]. Mean doses to the thyroid ranged from
0.1 Gy for tinea capitis to 1.4 Gy for thymic irradiation.
The highest ERR per Gray followed radiation for tinea
capitis and the lowest ERR was noted following tonsil
irradiation. In addition to these studies, Ron et al. [11]
pooled data from studies of radiation-related thyroid cancer
in children and adults that included 58,000 individuals
exposed to external radiation and 61,000 non-exposed
individuals. Among children younger than age 15 years at
exposure, Ron et al. noted a linear dose-response down to
0.1 Gy, and the ERR/Gy was 7.7 (95% CI, 2.1–28.7). The
corresponding EAR/10
4 PY/Gy for childhood exposure
was 4.4 (95% CI 1.9, 10.1). These studies demonstrated
that the thyroid gland is very sensitive to the carcinogenic
effects of radiation, characterized by a strong linear dose-
response down to 0.1 Gy. Risk for radiation-related thyroid
cancer decreased with increasing age at exposure and
persisted over time up to 30 years after radiation exposure.
Thyroid cancer risk was three times higher in females than
in males, similar to the background rates in the general
population.
Breast cancer
The studies of radiation treatment for enlarged thymus
gland [12] and hemangioma [13] have provided data on
radiation-related risk of breast cancer. The doses to the
breast ranged 20-fold in these studies, from 0.1 to 2.1 Gy.
Overall, the risk of breast cancer increased linearly with
increasing dose to the breast; risk decreased with increasing
age at exposure; and risk persisted up to 50 years after
exposure to radiation. In a pooled analysis of radiation
effects on breast cancer risk, Preston et al. [14] concluded
that the excess risk of breast cancer in the hemangioma
cohorts was about one-seventh of the risk in the thymic
cohort, likely due to low-dose-rate protracted exposures
from Ra-226 in the hemangioma cohorts compared to the
high-dose-rate exposures in the thymic cohort [14].
Leukemia
Mortality from leukemia was evaluated in the Israeli tinea
capitis [15] and the Swedish hemangioma [16] cohorts. In
the Israeli tinea study, the EAR/10
4/Gy was 0.9, based on a
mean average bone marrow dose of 0.3 Gy. No significant
association between dose (average bone marrow dose 0.1,
<0.01 to 4.6 Gy) and leukemia was detected in the
hemangioma cohort. Among those irradiated subjects in
the hemangioma cohort who received more than 0.1 Gy,
investigators estimated the ERR/Gy separately for leukemia
deaths occurring in childhood (5.0, 95% CI 0.1–15) and in
adulthood (−0.02, 95% CI −0.08–1.9). The combined ERR/
Gy was 1.6 (95% CI −0.6–5.5).
Brain tumors
Brain tumors, both malignant and benign, have been
reported following radiotherapy for tinea capitis [17, 18]
and hemangioma [19] following doses on the order of 1–
2 Gy. In the Israeli tinea study, the dose to the brain was
1.5 Gy (range 1–6 Gy), and the ERR/Gy was higher for
benign meningiomas than for malignant tumors (4.6, 95%
CI 2.4–9.1 vs. 1.98, 95% CI 0.7–4.7) after a median of
40 years of follow-up of the cohort. However, the ERR/Gy
decreased with increasing age at exposure for malignant
but not for benign tumors. Among the hemangioma cohort,
the mean absorbed intracranial dose was lower (0.07 Gy),
but had a wider range (<0.01–11.5 Gy). The ERR was 2.7/
Gy (95% CI 1.0–5.6) for malignant and benign tumors
combined, and the ERR decreased with increasing age at
exposure. Both of these studies noted a strong dose-
response, a decreasing risk of brain tumors with increasing
age at exposure, and an elevated risk 30 and more years
after exposure.
Non-melanoma skin cancer
Skin cancer on the scalp and face was evaluated following
radiotherapy for tinea capitis in both the New York [20] and
the Israeli series [21]. Doses ranged from 3 Gy to 6 Gy to
the scalp. In both studies, significantly increased risks for
skin cancer were noted for basal cell cancers only, and
these cancers appeared after a minimum latency of
20 years. The excess relative risks were higher for New
York; the ERR/Gy was 0.7 (95% CI 0.3–1.4) for the Israeli
series and the ERR/Gy was 1.6 (95% CI 1.3–2.1) for the
New York series. An interaction of ionizing radiation with
ultraviolet radiation was suggested by a preponderance of
skin cancers in sun-exposed areas and very few of these
cancers were diagnosed in blacks, who received the same
exposures.
Diagnostic radiation exposure in children
Many fewer studies have evaluated the cancer risk
following diagnostic radiation exposure in children
(Table 2). Unless diagnostic procedures are performed
multiple times, doses are typically low, and the sample
sizes required to detect a risk of cancer are often
impractically large. However, studies of radiation exposure
from multiple chest fluoroscopies used to monitor treat-
ment for tuberculosis (TB) in adolescent girls and young
women [22–25], and a study of multiple diagnostic X-ray
examinations to monitor curvature of the spine in girls with
scoliosis [26] have reported increased mortality from breast
cancer with increasing radiation dose. In the TB cohorts,
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dose-rate exposures ranged from 0.79 to 2.1 Gy, whereas in
the scoliosis cohort, the average breast dose was lower,
0.11 Gy. In these studies, the risk of breast cancer began to
appear 15 years after radiation exposure and the risk
remained elevated up to 50 years later. Based on the data
from the young women exposed to multiple chest
fluoroscopies during TB therapy, fractionation of the
radiation dose may not have had a sparing effect on the
excess breast cancer rates [14].
Two population-based case-control studies (China [27]
and Canada [28]) and one institutionally based study in the
US [29] of sufficient size have provided estimates of
radiation-related leukemia following postnatal diagnostic
X-ray examinations. A population-based study in Shang-
hai, China, reported a marginally elevated risk for acute
leukemia associated with diagnostic X-ray examinations
(odds ratio 1.6, 95% CI 1.0–2.6) among 166 children with
cancer compared with 166 controls. In a study of childhood
acute lymphoblastic leukemia (ALL) in Quebec, the risk
for ALL rose with increasing number of diagnostic X-ray
examinations (mostly bone examinations) from OR 1.04
for one examination to OR 1.61 for two or more
examinations, based on 491 patients and 491 controls.
The institutionally based study in the US of 1,842 children
with acute lymphoblastic leukemia and 1,986 controls
reported a slightly decreased risk for one or two X-ray
examinations (OR 0.9) and a modestly increased risk for
three or more X-ray examinations (OR 1.2).
A study of 674 children in Israel (1950–1970) [30]
measured cancer incidence, and a larger study of 3,915
children in Canada (1950–1965) [31, 32] evaluated cancer
incidence and mortality following cardiac catheterization
procedures. Individual dose estimates were not available,
but skin doses likely ranged from 0.05 to 0.47 Gy during
the time period of the study. Neither study reported an
overall increased risk of cancer. In Israel, risk decreased
with increasing number of procedures (OR 2.0 for one
procedure, OR 1.4 for two procedures) and the cancers
occurred in males only; in Canada, risks for cancer were
less than expected (OR 0.7 for one procedure and OR 0.8
for two procedures).
Conclusion
Many studies of radiation for treatment of benign diseases
and a few studies of diagnostic radiation exposure have
yielded much of the information on the risk for radiation-
related cancer in children. Although most cancers can be
induced by radiation, these studies demonstrate dose-
related increased risks of cancer of the thyroid, breasts and
brain, non-melanoma skin cancer, and leukemia. Risks
were related to radiation dose and appeared to be greatest
for children irradiated early in life, and risks for solid
tumors persisted throughout life.
Table 2 Cancer risk following diagnostic radiation exposure in childhood and adolescence (OR odds ratio)
Cancer
site
Underlying condition Cohort: study
size
Mean age
(years)
Dose
(Gy)
No. of X-ray
examinations
Risk estimate
Breast Tuberculosis USA: 1,494 15 0.8 ERR/Gy 0.4 (0.2–0.7)
Canada, Nova Scotia: 984 26 2.1 ERR/Gy 3.6 (1.8–6.8)
Canada, other: 12,094 26 0.8 ERR/Gy 0.4 (0.1–0.8)
Scoliosis USA: 5,573 10.6 0.1 ERR/Gy 2.7 (−0.2–9.3)
Leukemia Diagnostic X-ray
examinations of
broken bones
Canada: 491 patients
with acute lymphoblastic
leukemia, 491 controls
<10 1
≥2
OR 1.04 (95% CI 0.7–1.5)
OR 1.61 (95% CI 1.1–2.3)
Diagnostic X-ray
examinations
China: 166 patients
with acute leukemia,
166 controls
<15 ≥1 OR 1.6 (95% CI 1.0–2.6)
Diagnostic X-ray
examinations
US: 1,842 patients with
acute lymphoblastic
leukemia, 1986 controls
<15 ≤2
≥3
OR 0.9 (95% CI 0.8–1.1)
OR 1.2 (95% CI 1.0–1.6)
All sites Cardiac
catheterization
Israel: 674 8.9 0.05–0.4 OR 2.0 (95% CI 0.8–4.2),
one procedure
OR 1.4 (95% CI 0.4–3.5),
two procedures
Cardiac
catheterization
Canada: 3,915 3.8 0.2–0.5 OR 0.7 (95% CI 0.4–1.3),
one procedure
OR 0.8 (95% CI 0.3–1.7),
two procedures
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